The government's decision to bust the price as well as monopoly of Bayer's anti-cancer drug, through the process of compulsory licensing now opens up the field for the generic industry to follow suit and could well pave the way for the availability of cheaper drugs for lifestyle diseases. More generic companies could invoke the compulsory licensing clause of the Indian Patents Act, following Monday's decision to allow Natco Pharma to sell...
More »SEARCH RESULT
A historic move to make drugs affordable-G Ananthakrishnan
India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...
More »'Adani forcing farmers to vacate land'
-The Times of India Instead of creating happiness in the lives of farmers in adjacent villages, Adani power corporation has rendered them landless as their agricultural land is forcibly acquired by the district administration for requirement of the thermal power company. Once affluent, these farmers have now come below poverty line. Adani Thermal Power Corporation has acquired agricultural land in and around it's thermal power plant near Tiroda (Gondia). The state government gave...
More »Natco gets India’s first compulsory licence-CH Unnikrishnan
In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...
More »Gujarat 2002 and Modi’s Misdeeds by Anand Teltumbde
Ten years after the killings in Gujarat, Narendra Modi has neither expressed regret nor has he been held accountable for those mass deaths. Where do we go from here? Anand Teltumbde (tanandraj@gmail.com) is a writer and civil rights activist with the Committee for the Protection of Democratic Rights, Mumbai. Just thinking of it, a shiver runs down my spine. I had my own brush with how the Hindutva gangs carried out the...
More »